🇺🇸 FDA
Patent

US 8067423

Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

granted A61PA61P35/00A61P35/02

Quick answer

US patent 8067423 (Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00, A61P35/02, A61P35/04, A61P43/00